Gateway Investment Advisers’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$76.5M Sell
304,186
-13,696
-4% -$2.95M 0.76% 27
2026
Q1
$69.1M Sell
317,882
-58,398
-16% -$13M 0.77% 24
2025
Q4
$86M Buy
376,280
+4,229
+1% +$963K 0.8% 22
2025
Q3
$86.1M Buy
372,051
+3,230
+0.9% +$658K 0.83% 23
2025
Q2
$68.5M Sell
368,821
-17,145
-4% -$3.19M 0.75% 25
2025
Q1
$80.9M Buy
385,966
+15,915
+4% +$3.09M 0.93% 22
2024
Q4
$65.8M Sell
370,051
-69,230
-16% -$12.7M 0.73% 25
2024
Q3
$86.7M Sell
439,281
-279
-0.1% -$52.1K 0.96% 19
2024
Q2
$75.4M Sell
439,560
-1,892
-0.4% -$313K 0.85% 21
2024
Q1
$80.4M Sell
441,452
-32,998
-7% -$5.69M 0.92% 20
2023
Q4
$73.5M Sell
474,450
-364
-0.1% -$53.1K 0.86% 21
2023
Q3
$70.8M Sell
474,814
-1,113
-0.2% -$163K 0.89% 21
2023
Q2
$64.1M Sell
475,927
-935
-0.2% -$137K 0.76% 29
2023
Q1
$76M Sell
476,862
-10,784
-2% -$1.65M 0.93% 19
2022
Q4
$78.8M Sell
487,646
-28,295
-5% -$4.34M 0.97% 21
2022
Q3
$69.2M Sell
515,941
-30,197
-6% -$4.33M 0.87% 23
2022
Q2
$83.6M Buy
546,138
+21,345
+4% +$3.26M 0.94% 21
2022
Q1
$85.1M Sell
524,793
-25,000
-5% -$3.63M 0.84% 22
2021
Q4
$74.4M Sell
549,793
-30,337
-5% -$3.58M 0.71% 30
2021
Q3
$62.6M Sell
580,130
-24,806
-4% -$2.83M 0.65% 34
2021
Q2
$68.1M Sell
604,936
-4,112
-0.7% -$463K 0.7% 30
2021
Q1
$65.9M Sell
609,048
-19,398
-3% -$2.07M 0.71% 29
2020
Q4
$67.3M Sell
628,446
-34,221
-5% -$3.29M 0.74% 32
2020
Q3
$58M Sell
662,667
-1,334
-0.2% -$126K 0.67% 39
2020
Q2
$65.2M Sell
664,001
-82,051
-11% -$7.22M 0.77% 35
2020
Q1
$56.8M Buy
746,052
+114,212
+18% +$9.73M 0.7% 41
2019
Q4
$55.9M Sell
631,840
-12,784
-2% -$1.06M 0.55% 45
2019
Q3
$48.8M Sell
644,624
-44,924
-7% -$3.08M 0.49% 50
2019
Q2
$50.1M Sell
689,548
-85,382
-11% -$6.71M 0.45% 53
2019
Q1
$62.5M Sell
774,930
-34,309
-4% -$2.81M 0.55% 47
2018
Q4
$74.6M Buy
809,239
+1,206
+0.1% +$106K 0.71% 36
2018
Q3
$76.4M Sell
808,033
-13,856
-2% -$1.31M 0.64% 40
2018
Q2
$76.1M Sell
821,889
-49,343
-6% -$4.82M 0.67% 37
2018
Q1
$82.5M Sell
871,232
-11,229
-1% -$1.23M 0.73% 33
2017
Q4
$85.3M Sell
882,461
-37,804
-4% -$3.56M 0.73% 35
2017
Q3
$81.8M Sell
920,265
-2,610
-0.3% -$199K 0.71% 39
2017
Q2
$66.9M Buy
922,875
+46,908
+5% +$3.15M 0.6% 43
2017
Q1
$57.1M Sell
875,967
-54,778
-6% -$3.44M 0.52% 53
2016
Q4
$58.3M Sell
930,745
-90,263
-9% -$5.51M 0.55% 49
2016
Q3
$64.4M Sell
1,021,008
-37,495
-4% -$2.43M 0.57% 48
2016
Q2
$65.5M Sell
1,058,503
-15,076
-1% -$919K 0.56% 52
2016
Q1
$61.3M Sell
1,073,579
-59,992
-5% -$3.34M 0.53% 54
2015
Q4
$67.2M Sell
1,133,571
-109,988
-9% -$6.34M 0.56% 51
2015
Q3
$67.7M Buy
1,243,559
+16,038
+1% +$1.04M 0.6% 51
2015
Q2
$82.5M Buy
1,227,521
+12,951
+1% +$845K 0.69% 39
2015
Q1
$71.1M Buy
1,214,570
+27,452
+2% +$1.66M 0.59% 50
2014
Q4
$77.7M Sell
1,187,118
-115,116
-9% -$7.26M 0.64% 43
2014
Q3
$75.2M Sell
1,302,234
-14,787
-1% -$821K 0.59% 46
2014
Q2
$74.3M Sell
1,317,021
-183,886
-12% -$9.65M 0.58% 51
2014
Q1
$77.1M Sell
1,500,907
-111,265
-7% -$5.62M 0.63% 44
2013
Q4
$85.1M Sell
1,612,172
-24,092
-1% -$1.18M 0.68% 40
2013
Q3
$73.2M Buy
1,636,264
+13,767
+0.8% +$610K 0.62% 46
2013
Q2
$67.1M Buy
+1,622,497
New +$71M 0.58% 49

Other funds holding ABBV

Gateway Investment Advisers's ABBV Position: Q2 2026 in Review

Gateway Investment Advisers reduced its AbbVie (ABBV) stake by 4.3% in Q2 2026, selling an estimated $2.95M and leaving 304,186 shares worth $76.5M. The position accounts for 0.76% of the portfolio, ranked #27.

Gateway Investment Advisers first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $86.7M in Q3 2024. 1,316 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Gateway Investment Advisers held 304,186 shares of AbbVie worth $76.5M as of Q2 2026.
  • Gateway Investment Advisers sold 13,696 AbbVie shares in Q2 2026, an estimated $2.95M.
  • AbbVie made up 0.76% of Gateway Investment Advisers's portfolio in Q2 2026, its #27 holding.
  • Gateway Investment Advisers first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Gateway Investment Advisers's AbbVie position peaked at $86.7M in Q3 2024.
  • 1,316 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.